SynOx Therapeutics raises $75m in fresh funding round
Iirsh and UK firm has raised more than $100 million to date
Source: irishtimes.com
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/FWDFOT2RX5EVRHSHQ64VJBQU7Q.jpg)
Dirk Kersten News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dirk Kersten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dirk Kersten Today - Breaking & Trending Today
Biopharma firm SynOx Therapeutics raises $75m in funding round
Biopharmaceutical company SynOx Therapeutics has raised $75m (€70.5m) to continue its development of a treatment for Tenosynovial Giant Cell Tumour (TGCT).
Source: independent.ie
Dyne Therapeutics (NASDAQ:DYN) Trading Down 3%
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) traded down 3% on Thursday . The stock traded as low as $27.57 and last traded at $27.89. 552,733 shares were traded during mid-day trading, a decline of 75% from the average session volume of 2,206,098 shares. The stock had previously closed at $28.76. Wall Street Analysts […]
Source: wkrb13.com
Dyne Therapeutics (NASDAQ:DYN) Trading Down 3%
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report)’s stock price was down 3% during mid-day trading on Thursday . The stock traded as low as $27.57 and last traded at $27.89. Approximately 552,733 shares were traded during trading, a decline of 75% from the average daily volume of 2,206,098 shares. The stock had previously closed […]
Source: tickerreport.com
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Rating of "Buy" by Brokerages
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been given an average rating of “Buy” by the seven research firms that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]
Source: dailypolitical.com